deltatrials
Completed PHASE4 INTERVENTIONAL 3-arm NCT03368495

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines in Children Under 2 Years Old in Argentina

Sponsor: Alba Maria Ropero

Conditions Vaccine Response Impaired
Interventions Co-administration of MMR/YF MMR followed by YF YF followed by MMR
Updated 7 times since 2017 Last updated: May 17, 2019 Started: Nov 23, 2015 Primary completion: Jun 30, 2018 Completion: Jun 30, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03368495, this PHASE4 trial focuses on Vaccine Response Impaired and remains completed. Sponsored by Alba Maria Ropero, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshotRecruiting~Jun 2018 – ~Jun 2019 · 12 months · monthly snapshotRecruiting~Jun 2019 – ~Jan 2021 · 19 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jun 2019 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

▶ Show 2 earlier versions

  1. Jun 2018 — Jun 2019 [monthly]

    Recruiting PHASE4

  2. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alba Maria Ropero
  • Centers for Disease Control and Prevention
  • Ministry of Public Health, Argentina
Data source: Pan American Health Organization

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations